RecruitingNot Applicable

Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography

Denmark120 participantsStarted 2024-07-01

Plain-language summary

The aim of this study is to compare AMG and EMG (Philips IntelliVue NMT module and Senzime TetraGraph) in the objective monitoring of neuromuscular blocking in children between the age of 6 months and 2 years.The monitoring will be done bilaterally either on n.ulnaris or n. tibialis. The hypothesis of the study is that AMG will indicate faster recovery time (time to return to TOF 90%) from neuromuscular block than EMG.

Who can participate

Age range6 Months – 2 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients 6 months - 2 years of age * Scheduled for elective surgery under general anaesthesia with intubation and use of rocuronium * American Society of Anesthesiologists (ASA) physical status classification I to III Exclusion Criteria: * Known allergy to rocuronium * Neuromuscular disease that may interfere with neuromuscular data * Indication for rapid sequence induction * Prone position

What they're measuring

Time from injection of rocuronium until appearance of the first TOF ratio ≥ 90

Timeframe: 12 Hours

Trial details

NCT IDNCT06409260

SponsorMatias Vested

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09-15

Contact for this trial

Matias Vested

+4535455747 matias.vested@regionh.dk

View on ClinicalTrials.gov More Neuromuscular Blockade trials